for Cardiovascular Education
Diabetes & CVD
Kidney disease & CVD
LDL-c goal attainment in high risk patients
Promising results in pivotal trials of novel lipid-modifying drugs
3' education - Dec. 12, 2016 - Amsterdam, The Netherlands - Prof. John JP Kastelein, MD (AMC Amsterdam, The Netherlands)
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: